博士論文
ImageImageImage

A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer

Persistent ID (NDL)
info:ndljp/pid/11378109
Material type
博士論文
Author
NOGUCHI, Emi
Publisher
-
Publication date
2019-03-31
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
千葉大学 = Chiba University,博士(医学)
View All

Notes on use at the National Diet Library

Notes on use

Note (General):

type:text研究科: 千葉大学大学院医学薬学府(先端医学薬学専攻)学位記番号: 千大院医薬博甲第医1565号

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • Chiba University Repository for Access to Outcomes from Research

    Digital
    You can check the holdings of institutions and databases with which 学術機関リポジトリデータベース(IRDB)(機関リポジトリ) is linked at the site of 学術機関リポジトリデータベース(IRDB)(機関リポジトリ).

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
NOGUCHI, Emi
Author Heading
Publication Date
2019-03-31
Publication Date (W3CDTF)
2019-03-31
Alternative Title
HER2陽性日本人転移性乳癌を対象としたトラスツズマブ エムタンシンおよびペルツズマブ併用投与の安全性および薬物動態の第Ib相試験
Degree grantor/type
千葉大学 = Chiba University
Date Granted
2019-03-31
Date Granted (W3CDTF)
2019-03-31